Concepedia

Eranga R. Balasooriya

ER

6

Publications

374

Citations

6

H-Index

2017

Active since

Affiliations

Harvard University(Current)

Brigham Young University

Center for Cancer Research

Duke University

Massachusetts General Hospital

Eranga R. Balasooriya is an author at Harvard University specializing in green chemistry, nanocatalysis, and natural sciences.

ORCID

Top concepts

Publications per year

2017–2024

6

Publications

6

Honey Mediated Green Synthesis of Nanoparticles: New Era of Safe Nanotechnology

Eranga R. Balasooriya, Chanika D. Jayasinghe, Uthpala A. Jayawardena et al. · Journal of Nanomaterials · 2017 · 176 citations · Full text

, , +17

Landscape of Clinical Resistance Mechanisms to FGFR Inhibitors in FGFR2-Altered Cholangiocarcinoma

Qibiao Wu, Haley Ellis, Giulia Siravegna et al. · Clinical Cancer Research · 2023 · 68 citations · Full text

BioID reveals an ATG9A interaction with ATG13‐ATG101 in the degradation of p62/SQSTM1‐ubiquitin clusters

Ashari Rashmi Kannangara, Daniel M. Poole, Colten M. McEwan et al. · EMBO Reports · 2021 · 64 citations · Full text

, , +8

TNK1 is a ubiquitin-binding and 14-3-3-regulated kinase that can be targeted to block tumor growth

Tsz‐Yin Chan, Christina M. Egbert, Julia E. Maxson et al. · Nature Communications · 2021 · 31 citations · Full text

FGFR inhibition blocks NF-ĸB-dependent glucose metabolism and confers metabolic vulnerabilities in cholangiocarcinoma

Yuanli Zhen, Kai Liu, Lei Shi et al. · Nature Communications · 2024 · 22 citations · Full text

Rows per page

1–5 of 6